{"schema_version":"secwatch.filing_event.v1","accession":"0001607062-21-000331","form_type":"8-K","ticker":"RGBP","cik":"0001589150","company_name":"Regen BioPharma Inc","filed_at":"2021-09-16T23:59:59+00:00","discovered_at":"2026-05-14T18:04:18.702992+00:00","generated_at":"2026-06-29T03:14:42.291507+00:00","sec_items":["1.01","9.01"],"event_type":"litigation","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Regen Biopharma settles ChemDiv lawsuit for $800k, contingent on SEC filing by Sept 24","bullets":["Regen to pay $800k lump sum by Sept 30, 2021, to settle ChemDiv's breach-of-contract lawsuit over ~$1.2M unpaid invoices.","Settlement contingent on Regen filing acceptable SEC documents by Sept 24 to maintain listing status.","Upon payment, ChemDiv dismisses litigation with prejudice and transfers NR2F6 research data, compounds, and IP to Regen and Zander.","If payment not made by Sept 30, agreement void and litigation continues with trial set for Oct 29, 2021."],"urls":{"canonical":"https://secwatch.observer/filing/0001607062-21-000331","json":"https://secwatch.observer/filing/0001607062-21-000331.json","markdown":"https://secwatch.observer/filing/0001607062-21-000331.md","text":"https://secwatch.observer/filing/0001607062-21-000331.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1589150/000160706221000331/0001607062-21-000331-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1589150/000160706221000331/rgbp091521form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T03:14:42.291507+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}